Protein prenylation: A pivotal posttranslational process

Biochemical and Biophysical Research Communications

Volumn 303, Issue 1, 2003, Pages 1-7

  Roskoski Jr , Robert ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLALLYLTRANSFERASE; PROTEIN; PROTEIN FARNESYLTRANSFERASE; MAGNESIUM; METAL; P21(RAS) FARNESYL PROTEIN TRANSFERASE; P21(RAS) FARNESYL-PROTEIN TRANSFERASE; TRANSFERASE;

ALPHA CHAIN; KINETICS; PRENYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTON TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMICAL MODEL; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; METABOLISM;

ALKYL AND ARYL TRANSFERASES; ANIMALS; DIMETHYLALLYLTRANSTRANSFERASE; HUMANS; KINETICS; MAGNESIUM; METALS; MODELS, CHEMICAL; PROTEIN ISOPRENYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBSTRATE SPECIFICITY;

EID: 0037470819     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00323-1     Document Type: Review

References (30)

1. Zhang F.L., Casey P.J. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:1996;241-269. Reviews the early work on the discovery and properties of protein prenyltransferases, CaaX endoproteolysis, and methyl esterification.
2. Clarke S. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 61:1992;355-386. Traces the early work on the discovery of peptide and protein prenylation.
3. Cox A.D., Der C.J. Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? Biochim. Biophys. Acta. 1333:1997;F51-F71.
4. O'Donovan C., Martin M.J., Gattiker A., Gasteiger E., Bairoch A., Apweiler R. High-quality protein knowledge resource: SWISS-PROT and TrEMBL brief. Bioinformatics. 3:2002;275-284. or http://us.expasy.org/sprot/, this is the source for the sequence and postulated functions of the various proteins depicted in Table 1.
5. Barbacid M. ras Genes. Annu. Rev. Biochem. 56:1987;779-827.
6. Lowy D.R., Willumsen B.M. Function and regulation of Ras. Annu. Rev. Biochem. 62:1993;851-891.
7. Gibbs J.B. Farnesyltransferase inhibitors. third ed. Tamanoi F., Sigman D.S. The Enzymes. vol. XXI:2001;81-103 Academic Press, San Diego.
8. Sebti S.M., Hamilton A.D. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies. Oncogene. 19:2000;6584-6593.
9. Caponigro F. Farnesyl transferase inhibitors: a major breakthrough in anticancer therapy? Anticancer Drugs. 13:2002;891-897.
10. Hahn S.M., Bernhard E.J., Regine W., Mohiuddin M., Haller D.G., Stevenson J.P., Smith D., Pramanik B., Tepper J., DeLaney T.F., Kiel K.E., Morrison B., Deutsch P., Muschel R.J., McKenna W.G. A phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. Clin. Cancer Res. 8:2002;1065-1072.
11. Kurzrock R., Cortes J., Kantarjian H. Clinical development of farnesyltransferase inhibitors in leukemias and myelodysplastic syndrome. Semin. Hematol. 39:2002;20-24.
12. Dy G.K., Adjei A.A. Farnesyltransferase inhibitors in breast cancer therapy. Cancer Invest. 20(Suppl. 2):2002;30-37.
13. Seabra M.G. Biochemistry of Rab geranylgeranyltransferase. 3rd ed. Tamanoi F., Sigman D.S. The Enzymes. vol. XXI:2001;131-154 Academic Press, San Diego. Reviews the mechanistic and X-ray crystallographic studies of GGTase-II.
14. Yokayama K., Gelb M.H. Protein geranylgeranyltransferase type I. 3rd ed. Tamanoi F., Sigman D.S. The Enzymes. vol. XXI:2001;105-130 Academic Press, San Diego.
15. Armstrong S.A., Hannah V.C., Goldstein J.L., Brown M.S. CAAX geranylgeranyltransferase transfers farnesyl as efficiently as geranylgeranyl to RhoB. J. Biol. Chem. 270:1995;7864-7868.
16. Spence R.A., Casey P.J. Mechanism of catalysis by protein farnesyltransferase. 3rd ed. Tamanoi F., Sigman D.S. The Enzymes. vol. XXI:2001;1-18 Academic Press, San Diego.
17. Terry K.L., Long S.B., Beese L.S. Structure of protein farnesyltransferase. 3rd ed. Tamanoi F., Sigman D.S. The Enzymes. vol. XXI:2001;19-46 Academic Press, San Diego. (Reviews the X-ray crystallographic studies of FTase).
18. Urano J., Yang W., Tamanoi F. Mutational analysis of protein farnesyltransferase. 3rd ed. Tamanoi F., Sigman D.S. The Enzymes. vol. XXI:2001;47-80 Academic Press, San Diego.
19. Hightower K.E., Huang C., Casey P.J., Fierke C.A. H-Ras peptide and protein substrates bind protein farnesyltransferase as an ionized thiolate. Biochemistry. 37:1998;15555-15562.
20. Huang C.C., Casey P.J., Fierke C.A. Evidence for a catalytic role of zinc in protein farnesyltranferase. J. Biol. Chem. 272:1997;20-23.
21. Saderholm M.J., Hightower K.E., Fierke C.A. Role of metals in the reaction catalyzed by protein farnesyltransferase. Biochemistry. 39:2000;12398-12405.
22. Zhang F.L., Casey P.J. Influence of metal ions on substrate binding and catalytic activity of mammalian protein geranylgeranyltransferase type-I. Biochem. J. 320:1996;925-932.
23. Dolence J.M., Poulter C.D. A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase. Proc. Natl. Acad. Sci. USA. 92:1995;5008-5011.
24. Huang C., Hightower K.E., Fierke C.A. Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state. Biochemistry. 39:2000;2593-2602.
25. Furfine E.S., Leban J.J., Landavazo A., Moomaw J.F., Casey P.J. Protein farnesyltransferases: kinetics of farnesyl pyrophosphate binding and product release. Biochemistry. 34:1995;6857-6862.
26. Tschantz W.R., Furfine E.S., Casey P.J. Substrate binding is required for release of product from mammalian protein farnesyltransferase. J. Biol. Chem. 272:1997;9989-9993.
27. Long S.B., Casey P.J., Beese L.S. Reaction path of protein farnesyltransferase at atomic resolution. Nature. 419:2002;645-650. Formulation of the reaction pathway for FTase and its relationship to the enzymology of GGTase-II.
28. Trentham D.R. Rate-determining processes and the number of simultaneously active sties of D-glyceraldehyde 3-phosphate dehydrogenase. Biochem. J. 122:1971;71-77.
29. Roskoski R. Jr., Ritchie P.A. Role of the carboxyterminal residue in peptide binding to protein farnesyltransferase and protein geranylgeranyltransferase. Arch. Biochem. Biophys. 356:1998;167-176.
30. Roskoski R. Jr., Ritchie P.A. Time-dependent inhibition of protein farnesyltransferase by a benzodiazepine peptide mimetic. Biochemistry. 40:2001;9329-9335.